Category Archives: Anti-counterfeiting

Court Ruling Threatens Drug Shortage Remedy

The Food and  Drug Administration may no longer be able to alleviate shortages in vital drugs by permitting the import of unapproved medicines following a decision by the Court of Appeals for the District of Columbia. The ruling of July 23, 2013 also raises broader questions about when and how FDA can “exercise regulatory discretion” […]
Also posted in FDA, Safety, Supply Chain | Tagged , , , , , , | 1 Comment

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen […]
Also posted in compliance, Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain | Tagged , , , , , | Leave a comment

FDA Finding Fuels Indian Crackdown on Sub-standard Drugs

By Mangesh Sai, Asia Correspondent. A routine monthly inspection carried out by the Food and Drugs Administration (FDA) authorities in the state of Maharashtra, India, last month noted an increase in the number of sub-standard drug samples raising apprehensions about the availability of safe and genuine drugs in the state. Officials pointed out that 26 […]
Also posted in Global, Guest Blog, IP, Safety | Tagged , , , , | Leave a comment
  • Categories

  • Meta